Tilray Brands, Inc. (TLRY)
NASDAQ: TLRY · Real-Time Price · USD
4.460
+0.040 (0.90%)
At close: Jul 13, 2026, 4:00 PM EDT
4.461
+0.001 (0.02%)
Pre-market: Jul 14, 2026, 5:11 AM EDT
Tilray Brands Market Cap
Tilray Brands has a market cap or net worth of $532 million as of July 14, 2026. Its market cap has increased by 27.45% in one year.
Market Cap
532.00M
Enterprise Value
629.15M
1-Year Change
27.45%
Ranking
Category
Stock Price
$4.46
Market Cap Chart
Since May 4, 2021, Tilray Brands's market cap has decreased from $9.87B to $532.00M, a decrease of -94.61%. That is a compound annual growth rate of -43.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 13, 2026 | 532.00M | -49.07% |
| Dec 31, 2025 | 1.04B | -13.05% |
| Dec 31, 2024 | 1.20B | -28.47% |
| Dec 29, 2023 | 1.68B | 2.13% |
| Dec 30, 2022 | 1.64B | -63.52% |
| Dec 31, 2021 | 4.51B | -54.31% |
| May 4, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioAge Labs | 968.40M |
| Amphastar Pharmaceuticals | 850.55M |
| Esperion Therapeutics | 819.46M |
| Ironwood Pharmaceuticals | 693.02M |
| Aquestive Therapeutics | 509.40M |
| Evolus | 429.37M |
| Emergent BioSolutions | 413.29M |
| Kamada | 411.78M |